Glaxo Claims Contrition and Changes in its Sales Practices

By
-
1
69

Following a record-setting spate of settlements, GlaxoSmithKline North America President Dierdre Connelly touts Glaxo’s move away from a sales model that encourages the misbehavior that got the company into trouble, and rejects the argument that fines and settlements are insufficient to change the industry’s behavior. “Our settlement … damaged our reputation and it hurt our morale,” she stated.

Article →

Previous articlePulling for a New Reality: from Mental Illness to Mental Wellness
Next articleBreaking Someone Out of the Behavioral Health Unit
Kermit Cole
Kermit Cole
Kermit Cole, MFT, founding editor of Mad in America, works in Santa Fe, New Mexico as a couples and family therapist. Inspired by Open Dialogue, he works as part of a team and consults with couples and families that have members identified as patients. His work in residential treatment — largely with severely traumatized and/or "psychotic" clients — led to an appreciation of the power and beauty of systemic philosophy and practice, as the alternative to the prevailing focus on individual pathology. A former film-maker, he has undergraduate and master's degrees in psychology from Harvard University, as well as an MFT degree from the Council for Relationships in Philadelphia. He is a doctoral candidate with the Taos Institute and the Free University of Brussels. You can reach him at [email protected].

1 COMMENT

LEAVE A REPLY